Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Myriad Genetics Inc to acquire Crescendo Bioscience


Wednesday, 5 Feb 2014 06:00am EST 

Safeguard Scientifics Inc:Says that its partner company, Crescendo Bioscience Inc signed an amended agreement to be acquired by Myriad Genetics Inc.Says for $270 mln, in cash, minus $25 mln for the repayment of a loan made to Crescendo by Myriad in 2011 and subject to further adjustment for Crescendo's cash, other indebtedness, working capital and other amounts to be determined in accordance with the acquisition agreement.Says transaction is expected to close in the fiscal quarter ending Mar. 31, 2014, pending satisfactory completion of customary closing conditions and regulatory approval.Says Crescendo's advisor on the transaction was Perella Weinberg Partners, and Cooley, LLP provided legal representation. 

Company Quote

37.29
0.12 +0.32%
1:22pm EDT